Infectious diseases

Clinical Articles iconClinical Articles

There’s been some confusion recently on whether we should or shouldn’t take ibuprofen to treat symptoms of COVID-19 – especially after the World Health Organization (WHO) changed its stance. After initially recommending people avoid taking ibuprofen to treat symptoms of the new coronavirus disease, as of March 19 the WHO now does not recommend avoiding ibuprofen to treat COVID-19 symptoms.

Clinical Articles iconClinical Articles

While the majority of patients infected with COVID-19 will not require treatment, there is new hope for those that do go on to become seriously ill. A few treatments developed for other illnesses are showing promise, says Clinical Microbiologist and Infectious Diseases Physician Dr Bernard Hudson.

Expert/s: Healthed
Clinical Articles iconClinical Articles

Prime Minister Scott Morrison has announced that anyone entering Australia must enter a 14-day self-quarantine period. Some questions have been raised as to how this new mandate would be administered and enforced. The answer to these questions relies on a somewhat complex patchwork of state and federal laws and whether relevant federal and state government emergency powers have been activated.

Clinical Articles iconClinical Articles

The antibiotic resistance threat is real. In the years to come, we will no longer be able to treat and cure many infections we once could.We’ve had no new classes of antibiotics in decades, and the development pipeline is largely dry. Each time we use antibiotics, the bacteria in our bodies become more resistant to the few antibiotics we still have.The problem seems clear and the solution obvious: to prescribe our precious antibiotics only when absolutely needed. Implementing this nationally is not an easy task. But Australia could take cues from other countries making significant progress in this area, such as Sweden.

Clinical Articles iconClinical Articles

Antibiotic resistance is by no means a new problem, but the latest CDC report into the phenomenon does outline some novel approaches to treating bacterial infection.The advice for slowing infections generally and resistance in particular will be familiar: vaccination, strict hygiene for medical facilities and personnel, and using antibiotics only when needed and for the shortest duration possible. The authors admit that these are only temporary measures however, especially given that some bacteria are now becoming resistant to disinfectants as well.Researchers are also working to develop new types of antibiotics to combat drug resistant bacteria, although most of these efforts are in the early stages. In the shorter term, research has indicated that using specific combinations of existing antibiotics can be effective where current therapies fail.

Expert/s: Ms Maria Cohut
Clinical Articles iconClinical Articles

Recently reported cases of the often fatal bacterial infection leptospirosis in dogs in Sydney have raised the issue of animal diseases that also affect humans.This zoonotic disease is spread by rats and other rodents. However, this latest cluster in dogs has not been accompanied by human cases in the Sydney area so far; dog cases aren’t always accompanied by human cases nearby.

Clinical Articles iconClinical Articles

Trichophyton verrucosum is a cosmopolitan zoophilic dermatophyte. The normal host for this organism is cattle and occasionally horses. Human infection is acquired through direct contact with these animals or contaminated fomites, usually following minor trauma to the skin.Figure 1. Case 4 developed lesion after contact with beef cattle

Aim

To review cases of T. verrucosum infection diagnosed over a five year period.

Method

The Sullivan Nicolaides Pathology data base from 2009 – 2014 was searched for isolates of T. verrucosum.The laboratory services Queensland and extends into New South Wales as far south as Coffs Harbour.

Results

Seven cases of T. verrucosum over a five year period time frame that identified more than 12,500 dermatophyte infections in total.The most recent case (7) was a 54-year-old retired meat worker who owns a small property with one beef and three dairy calves all of which suffered from fungal infection. After clearing lantana and sustaining multiple scratches he developed a non-healing inflammatory lesion on his forearm which healed after three weeks of oral griseofulvin with some residual scarring.Biopsy, bacterial and fungal cultures all demonstrated fungal infection and cultures grew T. verrucosum. Scrapings collected from his infected cattle also demonstrated large spore ectothrix infection and grew this dermatophyte.Cases included six males and one female (Table 1). The age ranged from 27–71, mean 45 years.All except one (Case 5) had association with cattle with one also with horses. The site of infection was the forearm (5) (figure 1), leg (1) and face (1). Case 6 developed her leg lesion after birdwatching and camping on a cattle property although did not have direct contact with cattle.Three patients underwent skin biopsy and histology and in only one was hyphae seen on tissue sections.Four of five bacterial cultures also grew T. verrucosum on bacterial agar. Unlike other dermatophytes growth is enhanced at 37OC. The cases were concentrated in SE Queensland and Northern NSW.Four of the cases required systemic antifungal therapy to clear and a number were treated with several courses of antibiotics prior to the diagnosis being established.
Case No.LocationSex/AgeSiteFungal MicroscopyContactTreatment
1Kyogle, NSWM/32ForearmNo hyphaeCattleBifonazole T
2Avondale, NSWM/64ForearmHyphae 1+Cattle/horsesTerbinafine
3Clarenza, NSWM/27ForearmNo hyphaeCattleNo treatment
4Charleville, QldM/35ForearmNo hyphaeCattleKetaconazole T
5Boonah, QldF/71Lower legHyphae 1+Cattle propertyKetoconazole O
6Kingstown, NSWM/29FaceHyphae 1+CattleGriseofulvin O
7Buccan, QldM/54ForearmHyphae 1+CattleGriseofulvin O
Table 1: Culture positive cases T. verrucosum infection SNP 2009-2014

Conclusion

  1. verrucosum is an unusual zoonotic infection of the skin causing a highly inflammatory response involving the scalp, beard or exposed areas of the body in contact with cattle and horses.
Fluorescence under Wood’s ultra-violet light has been noted in cattle but not in humans.Unlike other dermatophytes, growth is enhanced at 37OC.Systemic therapy is usually required to clear the infection which is frequently mistaken for an inflammatory bacterial infection, initially being treated with antibiotics.Advice on clearing the infection from animals was seen as important.To read more or view the original summary click here - General Practice Pathology is a regular column each authored by an Australian expert pathologist on a topic of particular relevance and interest to practising GPs. The authors provide this editorial free of charge as part of an educational initiative developed and coordinated by Sonic Pathology.
Clinical Articles iconClinical Articles

Anyone living in country Australia should consider being vaccinated against Q fever, according to researchers.The recommendation was made on the basis of their study, published in the Medical Journal of Australia which showed that living in a rural area for more than three months was associated with an increased risk of contracting Q fever even if there was little contact with farm animals, the traditional reservoir of the infection.In fact, the risk among country dwellers was 2.5 times higher than among people who had never lived rurally, according to the study which looked for evidence of past infection among 2740 blood donors in Queensland and NSW.“The prevalence of Q fever, caused by Coxiella burnetii, is substantial in Australia despite the availability of a safe and effective vaccine,” the study authors wrote.They point to stats that show that between 2013 and 2017 there were more 2500 notifications of Q fever in this country. They say this is very likely to be an underestimate, as most infections (up to 80%) are asymptomatic and sometimes they may have non-specific symptoms.But what we do know is that when Q fever does cause significant symptoms the morbidity can be substantial - pneumonia, hepatitis, endocarditis, and osteomyelitis. In addition, 10-15% of symptomatic patients will develop a protracted post-Q fever fatigue syndrome.To check just how many people have or have had the condition, researchers assessed blood donors from metropolitan Sydney and Brisbane, as well as blood donors in rural areas, namely the Hunter New England region of NSW and Toowoomba in Queensland. As well as collecting data on exposure, occupation and vaccination, the sera of the subjects was tested for both the C. burnetii antibody (as a measure of past exposure) and C. burnetii DNA (measuring current infection).No patient in the study was found to be currently infected with Q fever.Overall, 3.6% of the participants had evidence of past infection. And even though seroprevalence was higher in the rural areas compared to metropolitan areas, a significant proportion of those people from the city who tested positive for past Q fever had a history of living in the country at some time in the past.As you would expect, people working with sheep, cattle or goats, abattoir workers and people who had assisted at an animal birth were at highest risk. Vaccination of these people is already recommended.Non-farming people who just lived in rural areas were found to be at risk.“Having lived in a rural area, but with no or rare contact with sheep, cattle or goats, was itself an independent predictor of antibody seropositivity after accounting for the effects of other exposures”, the study authors said.Hence the recommendation we vaccinate everyone living in the country. But, as an accompanying editorial points out, expanding the current vaccination program is not without its challenges. Screening for humoral antibody and cell-mediated skin testing is required prior to vaccination so the need for at least two GP visits, access to intradermal skin testing and the cost are all potential barriers, the editorial authors said.There is also an issue with a lack of evidence about the safety and effectiveness of the Q fever vaccine in children.Nonetheless, all the experts agree: if we want to reduce the burden of Q fever in Australia, we will need to look beyond the select populations we are currently targeting for vaccination because there are obviously risk factors other than sheep, cattle and goats, at play.

References

Gidding HF, Faddy HM, Durrheim DN, Graves SR, Nguyen C, Hutchinson P, Massey P, Wood N. Seroprevalence of Q fever among metropolitan and non‐metropolitan blood donors in New South Wales and Queensland, 2014–2015. Med J Aust. 2019 Apr; 210(7): 309-15. DOI: 10.5694/mja2.13004Francis JR, Robson JM. Q fever: more common than we think, and what this means for prevention. Med J Aust. 2019 Apr; 210(7): 305-6. DOI: 10.5694/mja2.50024

Upcoming Healthed Webcast

Abnormal LFTs – Practical Cases Expert Q&A

Tuesday 28th April, 7pm - 9pm AEST

Speaker

Prof Simone Strasser

Hepatologist; Royal Prince Alfred Hospital

Join Prof Simone Strasser for the upcoming webcast, where they will discuss with A/Prof Ralph Audehm, by means of a series of primary care case studies, the framework for interpreting abnormal liver function tests.